Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy

OBJECTIVES. Rituximab is an anti-CD20 monoclonal antibody that promotes better treatment outcomes in patients with non-Hodgkin's lymphoma (NHL). Case series of progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab within polychemotherapy regimens have led to the intro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tuccori, Marco, Focosi, Daniele, Blandizzi, Corrado, Pelosini, Matteo, Montagnani, Sabrina, Maggi, Fabrizio, Pistello, Mauro, Antonioli, Luca, Fornai, Matteo, Pepe, Pasquale, Rossi, Giuseppe, Petrini, Mario
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2010
Assuntos:
Lymphoma
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3227905/
https://ncbi.nlm.nih.gov/pubmed/21041380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0098
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados